80 related articles for article (PubMed ID: 9230279)
1. Differences in the p53 gene mutational spectra of prostate cancers between Japan and Western countries.
Watanabe M; Fukutome K; Shiraishi T; Murata M; Kawamura J; Shimazaki J; Kotake T; Yatani R
Carcinogenesis; 1997 Jul; 18(7):1355-8. PubMed ID: 9230279
[TBL] [Abstract][Full Text] [Related]
2. p53 gene mutations in human prostate cancers in Japan: different mutation spectra between Japan and western countries.
Watanabe M; Ushijima T; Kakiuchi H; Shiraishi T; Yatani R; Shimazaki J; Kotake T; Sugimura T; Nagao M
Jpn J Cancer Res; 1994 Sep; 85(9):904-10. PubMed ID: 7961118
[TBL] [Abstract][Full Text] [Related]
3. Infrequent involvement of p53 gene mutations in the tumourigenesis of Japanese prostate cancer.
Uchida T; Wada C; Shitara T; Egawa S; Koshiba K
Br J Cancer; 1993 Oct; 68(4):751-5. PubMed ID: 7691145
[TBL] [Abstract][Full Text] [Related]
4. p53 protein accumulation and gene mutation in the progression of human prostate carcinoma.
Navone NM; Troncoso P; Pisters LL; Goodrow TL; Palmer JL; Nichols WW; von Eschenbach AC; Conti CJ
J Natl Cancer Inst; 1993 Oct; 85(20):1657-69. PubMed ID: 7692074
[TBL] [Abstract][Full Text] [Related]
5. p53 in prostate cancer: frequent expressed transition mutations.
Chi SG; deVere White RW; Meyers FJ; Siders DB; Lee F; Gumerlock PH
J Natl Cancer Inst; 1994 Jun; 86(12):926-33. PubMed ID: 7515114
[TBL] [Abstract][Full Text] [Related]
6. p53 is mutated in a subset of advanced-stage prostate cancers.
Bookstein R; MacGrogan D; Hilsenbeck SG; Sharkey F; Allred DC
Cancer Res; 1993 Jul; 53(14):3369-73. PubMed ID: 8324747
[TBL] [Abstract][Full Text] [Related]
7. Mutations in the p53 gene in schistosomal bladder cancer: a study of 92 tumours from Egyptian patients and a comparison between mutational spectra from schistosomal and non-schistosomal urothelial tumours.
Warren W; Biggs PJ; el-Baz M; Ghoneim MA; Stratton MR; Venitt S
Carcinogenesis; 1995 May; 16(5):1181-9. PubMed ID: 7767983
[TBL] [Abstract][Full Text] [Related]
8. p53 abnormalities in primary prostate cancer: single-strand conformation polymorphism analysis of complementary DNA in comparison with genomic DNA. The Cooperative Prostate Network.
Gumerlock PH; Chi SG; Shi XB; Voeller HJ; Jacobson JW; Gelmann EP; deVere White RW
J Natl Cancer Inst; 1997 Jan; 89(1):66-71. PubMed ID: 8978408
[TBL] [Abstract][Full Text] [Related]
9. APC gene mutations in human prostate cancer.
Watanabe M; Kakiuchi H; Kato H; Shiraishi T; Yatani R; Sugimura T; Nagao M
Jpn J Clin Oncol; 1996 Apr; 26(2):77-81. PubMed ID: 8609698
[TBL] [Abstract][Full Text] [Related]
10. Molecular pathology of primary and metastatic ductal pancreatic lesions: analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions.
Ruggeri BA; Huang L; Berger D; Chang H; Klein-Szanto AJ; Goodrow T; Wood M; Obara T; Heath CW; Lynch H
Cancer; 1997 Feb; 79(4):700-16. PubMed ID: 9024708
[TBL] [Abstract][Full Text] [Related]
11. p53 Immunostaining guided laser capture microdissection (p53-LCM) defines the presence of p53 gene mutations in focal regions of primary prostate cancer positive for p53 protein.
Griewe GL; Dean RC; Zhang W; Young D; Sesterhenn IA; Shanmugam N; McLeod DG; Moul JW; Srivastava S
Prostate Cancer Prostatic Dis; 2003; 6(4):281-5. PubMed ID: 14663467
[TBL] [Abstract][Full Text] [Related]
12. Mutation of the tumor suppressor gene p53 in human prostate and bladder cancers--investigation by temperature gradient gel electrophoresis (TGGE).
Schlechte HH; Schnorr D; Löning T; Rudolph BD; Pohrt UM; Loening SA
J Urol; 1997 Mar; 157(3):1049-53. PubMed ID: 9072541
[TBL] [Abstract][Full Text] [Related]
13. [Androgen receptor gene mutations and p53 gene analysis in advanced prostate cancer].
Castagnaro M; Yandell DW; Dockhorn-Dworniczak B; Wolfe HJ; Poremba C
Verh Dtsch Ges Pathol; 1993; 77():119-23. PubMed ID: 7511268
[TBL] [Abstract][Full Text] [Related]
14. p53 gene alterations in prostate cancer after radiation failure and their association with clinical outcome: a molecular and immunohistochemical analysis.
Rakozy C; Grignon DJ; Li Y; Gheiler E; Gururajanna B; Pontes JE; Sakr W; Wood DP; Sarkar FH
Pathol Res Pract; 1999; 195(3):129-35. PubMed ID: 10220791
[TBL] [Abstract][Full Text] [Related]
15. p53 mutations occur in clinical, but not latent, human prostate carcinoma.
Konishi N; Hiasa Y; Hayashi I; Matsuda H; Tsuzuki T; Ming T; Kitahori Y; Shiraishi T; Yatani R; Shimazaki J
Jpn J Cancer Res; 1995 Jan; 86(1):57-63. PubMed ID: 7737911
[TBL] [Abstract][Full Text] [Related]
16. Mutations of the K-ras and p53 genes in gastric adenocarcinomas from a high-incidence region around Florence, Italy.
Hongyo T; Buzard GS; Palli D; Weghorst CM; Amorosi A; Galli M; Caporaso NE; Fraumeni JF; Rice JM
Cancer Res; 1995 Jun; 55(12):2665-72. PubMed ID: 7780983
[TBL] [Abstract][Full Text] [Related]
17. Mutations of ras genes are relatively frequent in Japanese prostate cancers: pointing to genetic differences between populations.
Shiraishi T; Muneyuki T; Fukutome K; Ito H; Kotake T; Watanabe M; Yatani R
Anticancer Res; 1998; 18(4B):2789-92. PubMed ID: 9713462
[TBL] [Abstract][Full Text] [Related]
18. Detection of human papillomavirus DNA and p53 gene mutations in human prostate cancer.
Suzuki H; Komiya A; Aida S; Ito H; Yatani R; Shimazaki J
Prostate; 1996 May; 28(5):318-24. PubMed ID: 8610059
[TBL] [Abstract][Full Text] [Related]
19. Association of p53 mutations with metastatic prostate cancer.
Eastham JA; Stapleton AM; Gousse AE; Timme TL; Yang G; Slawin KM; Wheeler TM; Scardino PT; Thompson TC
Clin Cancer Res; 1995 Oct; 1(10):1111-8. PubMed ID: 9815901
[TBL] [Abstract][Full Text] [Related]
20. Allelic frequency of p53 gene codon 72 polymorphism in urologic cancers.
Wu WJ; Kakehi Y; Habuchi T; Kinoshita H; Ogawa O; Terachi T; Huang CH; Chiang CP; Yoshida O
Jpn J Cancer Res; 1995 Aug; 86(8):730-6. PubMed ID: 7559095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]